Last Updated : March 27, 2006
Details
FilesGeneric Name:
Insulin glargine (rDNA origin)
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, Type 1 & 2
Manufacturer:
Sanofi-Aventis Canada Inc.
Brand Name:
Lantus
Project Line:
Reimbursement Review
Project Number:
SR0058-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Resubmission
Indications:
Diabetes mellitus, Type 1 & 2
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : March 27, 2006